Eli Lilly and Co
Change company Symbol lookup
Select an option...
LLY Eli Lilly and Co
ADN Advent Technologies Holdings Inc
IMCC IM Cannabis Corp
ABGI ABG Acquisition I Corp
BPT BP Prudhoe Bay Royalty Trust
PBT Permian Basin Royalty Trust
SUN Sunoco LP
BP BP PLC
PSX Phillips 66
COP Conocophillips
Go

Health Care : Pharmaceuticals | Large Cap Growth
Company profile

Eli Lilly and Company is engaged in a drug manufacturing business. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes products include Basaglar, Humalog, Humulin, Jardiance, Trajenta, and Trulicity. Its oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. Its immunology products include Olumiant, Baricitinib, and Taltz. Its neuroscience products include Cymbalta, Emgality, and Zyprexa. Its other therapies consist of Bamlanivimab and etesevimab, Bebtelovimab, Cialis, and Forteo. It maintains special business groups to service wholesalers, pharmacy benefit managers, managed care organizations, group purchasing organizations, government and long-term care institutions, hospitals, and certain retail pharmacies. It manufactures and distributes its products through facilities in the United States, including Puerto Rico, and other countries. Its products are sold in about 120 countries.

Closing Price
$348.01
Day's Change
-1.72 (-0.49%)
Bid
--
Ask
--
B/A Size
--
Day's High
352.18
Day's Low
346.73
Volume
(Average)
Volume:
2,576,176

10-day average volume:
2,710,720
2,576,176

Upcoming Events

LLY's fiscal year ends in December
    • FEB
      14
      2023
    • Ex-dividend Date
    • Dividend amount
      $1.13
    • Record date
      February 15, 2023
    • Pay date
      March 10, 2023

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
November 1, 2022Q3 2022 Earnings Release$1.98$1.77 to $2.18$1.94
August 4, 2022Q2 2022 Earnings Release$1.25$1.43 to $1.95$1.87
April 28, 2022Q1 2022 Earnings Release$2.62$1.95 to $2.66$1.87
February 3, 2022Q4 2021 Earnings Release$2.49$2.18 to $2.53--

Past Dividends

Ex-dividend dateAmountRecord datePay date
November 14, 2022$0.98November 15, 2022December 9, 2022
August 12, 2022$0.98August 15, 2022September 9, 2022
May 13, 2022$0.98May 16, 2022June 10, 2022
February 14, 2022$0.98February 15, 2022March 10, 2022

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.